Conversation with The Cancer Letter Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdyNCI expects record-breaking spending on extramural research April 10, 2026Vol.52 No.14By Claire Marie Porter and Paul Goldberg
PodcastThe Directors The Directors: Wistar’s Altieri and ChristianaCare’s Petrelli say partnership of their institutions will go on as the guard changes March 27, 2026Vol.52 No.12By Sara Willa Ernst and Paul Goldberg
Podcast At a jam-packed NCAB meeting, cancer vaccines and site visits take center stage March 25, 2026
NCI Hoping to hit a $200M target, NCI and FNIH develop a plan for advancing cancer vaccinesNCI Director Letai: “How aggressive can we be?” March 20, 2026Vol.52 No.11By Claire Marie Porter
NCI Letai: “From this point forward, it really is much more like business as usual at the NCI.” March 20, 2026Vol.52 No.11By Jacquelyn Cobb
In Brief Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition March 06, 2026Vol.52 No.09
PodcastThe Directors The Directors: Yolanda Sanchez and Kelvin Lee talk about making cancer centers more resilient“Diverse ecosystems are more robust than non-diverse ecosystems. That is a biological fact.” February 27, 2026Vol.52 No.08By Claire Marie Porter and Paul Goldberg
NCI The FY26 funding package gave NCI a raise, but the institute’s buying power is 18% less than it was two decades agoLowy: “We still have percentiles, but we’re not allowed to make awards exclusively on the basis of payline.” February 13, 2026Vol.52 No.06By Jacquelyn Cobb
In Brief Team USA’s Julie Letai competes in Milan Olympics speed skating event February 13, 2026Vol.52 No.06
NCI Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural researchThe group replaced the NCI Board of Scientific Advisors February 06, 2026Vol.52 No.05By Claire Marie Porter
